Enterprise Value
-70.06K
Cash
8.236M
Avg Qtr Burn
-1.81M
Short % of Float
4.25%
Insider Ownership
15.70%
Institutional Own.
11.94%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IV Tramadol Details Post operative acute pain , Pain | Phase 3 Initiation | |
AJ201 Details Huntington's disease, Spinal and bulbar muscular atrophy , Spinocerebellar Ataxia | Phase 1/2 Update |